The main clinical indications included acute lymphoblastic leukaemia, Parkinson's disease, haemophilia, defects of the bladder, knee cartilage lesions, adenosine deaminase deficiency, melanoma, stroke, multiple sclerosis and retinal disease. Here, ADA is linked to acute lymphoblastic leukemia.